Sean Ainsworth, Chief Executive Officer and Chairman of the Board 

Oct. 11 | 2:15pm | Oxford Biomedica Ballroom   

Seattle, WA 


In-person Presentation 

Our mission at Immusoft is to develop novel cell therapies by programming B cells to produce therapeutic proteins that improve the lives of patients with rare diseases. 

By using this website you agree to accept our Privacy Policy and Terms & Conditions